AssureImmune is an adult stem cell bank currently developing cell therapy treatments. We are keeping a very close eye on authentic, FDA approved therapeutic outlets for stem cells. Our research team is involved in several projects, one of which addresses Critical Limb Ischemia – a common complication seen in diabetic patients. Dr. Claudia Zylberberg, PhD., Assureimmune Board Director, is invited to speak at the ICPQ Commercialization of Regenerative Medicine, December 12-13 in Philadelphia. This event will bring together pharmaceutical companies, the biotechnology industry, government, academics and investors focused on the commercialization of stem cells and regenerative medicine. Attendees will brainstorm to optimize clinical development, negotiate reimbursement, overcome strategic and regulatory challenges and navigate partnership opportunities. Last month, AssureImmune participated in conferences including the Age Management Medical Group in Las Vegas. We also conducted several workshops on the benets of stem cell therapies with physicians throughout the country and with our partner, Cenegenics.

FDA approves umbilical cord stem cell product
The U.S. Food and Drug Administration this week for the rst time approved a product made from stem cells taken from human umbilical cords. [All Headline News]
http://www.allheadlinenews.com/articles/90064541?FDA+approves+umbilical+cord+stem+cell+product

Stem Cells from Cord Blood Could Help Repair Damaged Heart Muscle
New research has found that stem cells derived from human cord blood could be an eective alternative in repairing heart [Science Daily]
http://www.sciencedaily.com/releases/2011/10/111013103647.htm

Autologous Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia
Investigators report the results of a prospective, randomized phase III trial evaluating the use of autologous peripheral blood stem cell transplantation vs. intensive consolidation chemotherapy in newly diagnosed acute myeloid leukemia patients in complete remission. [Blood]
http://bloodjournal.hematologylibrary.org/content/early/2011/09/27/blood-2011-07-370247.abstract

Patient-Specic Stem Cells: Major Step Toward Cell-Based Therapies for Life-Threatening Diseases
A team of scientists led by Dieter Egli and Scott Noggle at The New York Stem Cell Foundation (NYSCF) Laboratory in New York City has made an important advance in the development of patient-specic stem cells that could impact the study and treatment of diseases such as diabetes, Parkinson's, and Alzheimer's. [Science Daily]
http://www.sciencedaily.com/releases/2011/10/111006090029.htm

Umbilical cord cells may treat arthritis
Umbilical cord stem cells may be useful in the treatment of rheumatoid arthritis. Animal and in vitro experiments have shown that mesenchymal stem cells taken from umbilical cord blood can suppress inammation and attenuate collagen-induced arthritis. [Press release from EurekAlert! discussing online prepublication in Arthritis Research and Therapy]
http://www.eurekalert.org/pub_releases/2010-11/bc-ucc111210.php

Activartis Develops Dendritic Cell-Based Therapeutic Cancer Vaccine in Phase II
Activartis GmbH is developing a cancer immunotherapy concept which is currently in phase II clinical trials. Initially directed against aggressive brain cancer, it will, in principle, be applicable to all types of cancerous diseases. [b3c Newswire]
http://www.b3cnewswire.com/20111027608/activartis-develops-dendritic-cell-based-therapeutic-cancer-vaccine-in-phase-ii.html

FDA Approves Continuation of ALS Stem Cell Trial
Emory University researchers have received approval from the Food and Drug Administration (FDA) to advance to the next phase of a landmark trial to treat patients with Amyotrophic Lateral Sclerosis (ALS) using human neural stem cells. [Emory University]
http://shared.web.emory.edu/whsc/news/releases/2011/10/fda-approves-continuation-of-als-stem-cell-trial.html

Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Neuralstem, Inc. announced that it has received a notice of allowance from the U.S. Patent and Trademark Oce for patent application 12/418,170 pertaining to a "Spinal Platform and Method for Delivering a Therapeutic Agent to a Spinal Cord Target." [Neuralstem, Inc.]
http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-newsarticle&id=1616301&highlight

New National Tissue Engineering Centre to Develop Treatment for Early Osteoarthritis
Arthritis Research UK launched a £6 million experimental tissue engineering centre which aims to regenerate bone and cartilage by using patients’ own stem cells to repair the joint damage caused by osteoarthritis. [Arthritis Research UK]
http://www.arthritisresearchuk.org/about_us/arthritis_news/press_releases/2011/tissue_centre_launch.aspx

Scientists Successful in Rejuvenating Cells in Elderly Patients
 A research team has accomplished the rejuvenation of cells from elderly donors, which could prove to be benecial for regenerative medicine [DailyTech]
http://www.dailytech.com/Scientists+Successful+in+Rejuvenating+Cells+in+Elderly+Patients/article23222.htm

Pluristem sees positive data from stem cell trials
Pluristem Therapeutics had positive 12-month results from Phase I clinical trials for its PLX stem cells for the treatment of critical limb ischemia (CLI), the Israeli company said [Reuters]
http://in.reuters.com/article/2011/11/03/us-pluristem-trials-idINTRE7A22MA20111103

Stem Cells To Oer Therapeutic Hopes for Lung Diseases
A group of researchers from the Harvard Medical School and Brigham and Women’s Hospital have successfully cloned three unique stem cells from the human airways and have shown potential for them to be dierentiated into the lungs alveoli air sac tissues. [Healblog]
http://www.healblog.net/health-news/stem-cells-to-offer-therapeutic-hopes-for-lung-diseases/

UConn Developing Stem Cells to Repair Joint Cartilage
University of Connecticut Health Center researchers are developing stem cell therapies to repair joint cartilage. Associate professor Caroline Dealy discusses the process for developing these stem cell therapies, and the future commercialization of the research. [UConn Today]
http://today.uconn.edu/blog/2011/10/developing-stem-cells-to-repair-joint-cartilage/

World Conference on Regenerative Medicine 2011
November 2-4, 2011
Leipzig, Germany

National Cancer Research Institute Cancer Conference
November 6-9, 2011
Liverpool, United Kingdom

  Phacilitate: Oncology Leaders’ Forum 2011
November 7-9, 2011
November 7-9, 2011 Boston, United States

4th Northwest Genome Engineering Consortium (NGEC) Annual Workshop on Genome Engineering
November 8, 2011
Seattle, United States

21st Asia Pacic Cancer Conference 2011
November 10-12, 2011
Kuala Lumpur, Malays

2011 Bioreactor & Growth Environments for Tissue Engineering Training Course
November 14-16, 2011
Keele, United Kingdom

Cold Spring Harbor - Harnessing Immunity to Prevent and Treat Disease
November 16-19, 2011
Cold Spring Harbor, United States

PStem Cell Society Singapore Symposium 2011
November 17-18, 2011
Singapore, Singapore

22nd Regional Congress of the ISBT
November 19-23, 2011
Taipei, Taiwan
6th Annual Congress of the German Society for Stem Cell Research
November 20-22, 2011
Duesseldorf, Germany

American Association for Cancer Research International Conference New Horizons in Cancer Research: Biology to Prevention to Therapy
December 13-16, 2011
Gurgaon, India

Bench to Bedside: Blood and Marrow Transplantation
December 16, 2011
London, United Kingdom

Phacilitate Cell & Gene Therapy Forum 2012
January 30-February 1
Washington, United States
All materials are reserved by AssureImmune, LLC. For information regarding the use of this Newsletter or the allowed use of any of the materials contained in this Newsletter , please contact AssureImmune at info@assureimmune.com